微小RNA在结直肠癌上皮间质转化中的作用与研究进展OA
Research progress on the role of microRNA in epithelial-mesenchymal transition of colorectal cancer
结直肠癌(CRC)是全球第三大常见癌症,发病率仅次于肺癌和女性乳腺癌.上皮间质转化(EMT)不仅增强了CRC细胞的迁移和侵袭能力,还与CRC的复发和耐药性密切相关.微小RNA(miRNA)是一种非编码RNA,可以通过多种机制和途径调控EMT过程.本文综述了miRNA在CRC EMT中的作用及其研究进展,旨在为防治CRC转移提供新思路.
Colorectal cancer(CRC)is the third most common cancer globally,with an incidence rate ranked just behind lung cancer and breast cancer in women.Epithelial-mesenchymal transition(EMT)enhances the migratory and invasive abilities of tumor cells but is also closely associated with tumor recurrence and drug resistance.MicroRNAs(miRNAs)are a class of non-coding RNAs that regulate the EMT process through various mechanisms and pathways.Therefore,this review aims to summarize the roles and research progress of miRNAs in the regulation of EMT in CRC,providing new insights into the complex regulation of EMT and offering potential strategies for the prevention and treatment of CRC metastasis.
张涛;李辉龙;冯静;陈淼
四川大学华西医院临床药学部(成都 610041)重庆市巴南区接龙镇中心卫生院外科(重庆 401344)四川大学华西医院临床药学部(成都 610041)遂宁市检验检测中心(四川 遂宁 629000)
医药卫生
结直肠癌上皮间质转化微小RNA耐药性天然化合物
Colorectal cancerEpithelial-mesenchymal transitionMicroRNADrug resistanceNatural compound
《医学新知》 2026 (1)
103-109,7
评论